Knights Of Columbus Asset Advisors LLC Gilead Sciences, Inc. Transaction History
Knights Of Columbus Asset Advisors LLC
- $1.48 Billion
- Q3 2024
A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 150 shares of GILD stock, worth $13,861. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 150
-0.0%
Holding current value
$13,861
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding GILD
# of Institutions
1,927Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.7 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.07 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.71 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.56 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $116B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...